Terms: = Leukemia AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Diagnosis
1 results:
1. Plasma tyrosine kinase activity as a potential biomarker in BCR-ABL1-targeted therapy.
Yeh CH; Abdool A; Bruey JM
Cancer Biomark; 2010; 7(6):295-303. PubMed ID: 21694468
[TBL] [Abstract] [Full Text] [Related]
